Portugal will subsidise part of the cost of obesity medicines, SIC Notícias reported on Thursday. According to the broadcaster, the state will cover 15% of the price of these treatments for patients who are being monitored by a doctor.
The measure was also reported by Observador and The Portugal News, both of which put the state's share at 15% and tied eligibility to patients under medical follow-up.
The reporting so far gives few operational details. The available summaries do not specify a start date, a list of covered medicines or the budget involved, and none of the outlets quoted in the material named the officials behind the decision.
The announcement lands amid wider discussion of how obesity is treated in Portugal. The Jornal Económico reported that private hospitals are promoting a debate on obesity treatment in the country, and HealthNews reported that a platform called Recalibrar a Balança is pressing for the obesity programme to be carried out under the 2027 state budget, known in Portugal as OE2027.
Taken together, the coverage points to obesity care moving up the policy agenda, with the new subsidy framed as support for patients already in clinical care rather than a stand-alone measure.
What to watch next: the formal rules setting out which medicines qualify, when the subsidy takes effect and how patients are enrolled.